Cargando…
Microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery
BACKGROUND: Postoperative atrial fibrillation (POAF) is commonplace after cardiothoracic surgery. A rate control strategy using short-acting beta blockers is recommended as a first-line therapy in patients without hemodynamic instability. Microcirculatory effects of POAF and esmolol have not yet bee...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727878/ https://www.ncbi.nlm.nih.gov/pubmed/29233190 http://dx.doi.org/10.1186/s13054-017-1889-5 |
_version_ | 1783285970175524864 |
---|---|
author | Fornier, William Jacquet-Lagrèze, Matthias Collenot, Thomas Teixeira, Priscilla Portran, Philippe Schweizer, Rémi Ovize, Michel Fellahi, Jean-Luc |
author_facet | Fornier, William Jacquet-Lagrèze, Matthias Collenot, Thomas Teixeira, Priscilla Portran, Philippe Schweizer, Rémi Ovize, Michel Fellahi, Jean-Luc |
author_sort | Fornier, William |
collection | PubMed |
description | BACKGROUND: Postoperative atrial fibrillation (POAF) is commonplace after cardiothoracic surgery. A rate control strategy using short-acting beta blockers is recommended as a first-line therapy in patients without hemodynamic instability. Microcirculatory effects of POAF and esmolol have not yet been investigated. We hypothesized that POAF without hemodynamic instability would induce microvascular dysfunction which could be reversed by intravenous esmolol. METHODS: Twenty-five cardiothoracic surgical patients with POAF were included in the study. Microcirculation was assessed by peripheral near-infrared spectroscopy (NIRS) in association with a vascular occlusion test (VOT) before esmolol infusion, during incremental doses of esmolol (25, 50, 100, and 200 μg/kg/min), and after a return to sinus rhythm. Esmolol was given to control heart rate to between 60 and 90 beats/min. Regional tissue oxygen saturation variables (StO(2), StO(2) min, StO(2) max, and ∆StO(2)) and desaturation/resaturation speeds during VOT were recorded to evaluate the microcirculation. RESULTS: StO(2) and resaturation speed were significantly improved when POAF returned to sinus rhythm (StO(2) 64% ± 6 versus 67% ± 6, P < 0.01; resaturation speed 0.53%/s (0.42–0.97) versus 0.66%/s (0.51–1.04), P = 0.020). ∆StO(2) was significantly decreased after a return to sinus rhythm (7.9% ± 4.8 versus 6.1% ± 4.7, P = 0.026). During esmolol infusion, we found a significant decrease in both heart rate (P < 0.001) and blood pressure (P < 0.001), and a non-significant dose-dependent increase in StO(2) (P = 0.081) and resaturation speed (P = 0.087). CONCLUSION: POAF without hemodynamic instability is associated with significant impairment in the microcirculation which could be partially reversed by intravenous esmolol. |
format | Online Article Text |
id | pubmed-5727878 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57278782017-12-18 Microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery Fornier, William Jacquet-Lagrèze, Matthias Collenot, Thomas Teixeira, Priscilla Portran, Philippe Schweizer, Rémi Ovize, Michel Fellahi, Jean-Luc Crit Care Research BACKGROUND: Postoperative atrial fibrillation (POAF) is commonplace after cardiothoracic surgery. A rate control strategy using short-acting beta blockers is recommended as a first-line therapy in patients without hemodynamic instability. Microcirculatory effects of POAF and esmolol have not yet been investigated. We hypothesized that POAF without hemodynamic instability would induce microvascular dysfunction which could be reversed by intravenous esmolol. METHODS: Twenty-five cardiothoracic surgical patients with POAF were included in the study. Microcirculation was assessed by peripheral near-infrared spectroscopy (NIRS) in association with a vascular occlusion test (VOT) before esmolol infusion, during incremental doses of esmolol (25, 50, 100, and 200 μg/kg/min), and after a return to sinus rhythm. Esmolol was given to control heart rate to between 60 and 90 beats/min. Regional tissue oxygen saturation variables (StO(2), StO(2) min, StO(2) max, and ∆StO(2)) and desaturation/resaturation speeds during VOT were recorded to evaluate the microcirculation. RESULTS: StO(2) and resaturation speed were significantly improved when POAF returned to sinus rhythm (StO(2) 64% ± 6 versus 67% ± 6, P < 0.01; resaturation speed 0.53%/s (0.42–0.97) versus 0.66%/s (0.51–1.04), P = 0.020). ∆StO(2) was significantly decreased after a return to sinus rhythm (7.9% ± 4.8 versus 6.1% ± 4.7, P = 0.026). During esmolol infusion, we found a significant decrease in both heart rate (P < 0.001) and blood pressure (P < 0.001), and a non-significant dose-dependent increase in StO(2) (P = 0.081) and resaturation speed (P = 0.087). CONCLUSION: POAF without hemodynamic instability is associated with significant impairment in the microcirculation which could be partially reversed by intravenous esmolol. BioMed Central 2017-12-12 /pmc/articles/PMC5727878/ /pubmed/29233190 http://dx.doi.org/10.1186/s13054-017-1889-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Fornier, William Jacquet-Lagrèze, Matthias Collenot, Thomas Teixeira, Priscilla Portran, Philippe Schweizer, Rémi Ovize, Michel Fellahi, Jean-Luc Microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery |
title | Microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery |
title_full | Microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery |
title_fullStr | Microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery |
title_full_unstemmed | Microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery |
title_short | Microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery |
title_sort | microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727878/ https://www.ncbi.nlm.nih.gov/pubmed/29233190 http://dx.doi.org/10.1186/s13054-017-1889-5 |
work_keys_str_mv | AT fornierwilliam microvasculareffectsofintravenousesmololinpatientswithnormalcardiacfunctionundergoingpostoperativeatrialfibrillationaprospectivepilotstudyincardiothoracicsurgery AT jacquetlagrezematthias microvasculareffectsofintravenousesmololinpatientswithnormalcardiacfunctionundergoingpostoperativeatrialfibrillationaprospectivepilotstudyincardiothoracicsurgery AT collenotthomas microvasculareffectsofintravenousesmololinpatientswithnormalcardiacfunctionundergoingpostoperativeatrialfibrillationaprospectivepilotstudyincardiothoracicsurgery AT teixeirapriscilla microvasculareffectsofintravenousesmololinpatientswithnormalcardiacfunctionundergoingpostoperativeatrialfibrillationaprospectivepilotstudyincardiothoracicsurgery AT portranphilippe microvasculareffectsofintravenousesmololinpatientswithnormalcardiacfunctionundergoingpostoperativeatrialfibrillationaprospectivepilotstudyincardiothoracicsurgery AT schweizerremi microvasculareffectsofintravenousesmololinpatientswithnormalcardiacfunctionundergoingpostoperativeatrialfibrillationaprospectivepilotstudyincardiothoracicsurgery AT ovizemichel microvasculareffectsofintravenousesmololinpatientswithnormalcardiacfunctionundergoingpostoperativeatrialfibrillationaprospectivepilotstudyincardiothoracicsurgery AT fellahijeanluc microvasculareffectsofintravenousesmololinpatientswithnormalcardiacfunctionundergoingpostoperativeatrialfibrillationaprospectivepilotstudyincardiothoracicsurgery |